Eribulin Mesylate Injection
Product Images NDC 68083-592

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Eribulin Mesylate (NDC 68083-592). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gland Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Eribulin-spl-carton-label (Eribulin Spl Carton Label)

This text is pharmaceutical information for Eribulin Mesylate Injection, a cytotoxic agent used for intravenous administration. It provides details on dosage, usage instructions, storage conditions, and manufacturing information. The medication comes in single-dose vials containing 1 mg of eribulin mesylate in 2 mL of solution. Each mL of solution contains 0.5 mg of eribulin mesylate in dehydrated alcohol and water for injection. The text emphasizes the importance of discarding any unused portion of the solution and provides guidelines on storage temperature.*

FDA Label Image

Eribulin-spl-fig-1 (Eribulin Spl Fig 1)

FDA Label Image

Eribulin-spl-fig-2 (Eribulin Spl Fig 2)

FDA Label Image

Eribulin-spl-structure (Eribulin Spl Structure)

FDA Label Image

Eribulin-spl-vial-label (Eribulin Spl Vial Label)

This text provides information on a medication called Eribulin Mesylate in the form of an injection. It contains 1 mg per 2 mL (0.5 mg/mL) of the medication for intravenous use in a single-dose vial. The text also includes storage instructions, dosage details, and a caution that it is a cytotoxic agent. The medication is manufactured by Gland Pharma Limited in Andhra Pradesh, India. Additional details such as lot number, expiry date, and a code are also provided.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.